These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37459457)

  • 1. Staging of Cervical Cancer: A Practical Approach Using MRI and FDG PET.
    Lakhman Y; Aherne EA; Jayaprakasam VS; Nougaret S; Reinhold C
    AJR Am J Roentgenol; 2023 Nov; 221(5):633-648. PubMed ID: 37459457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality Imaging of Uterine Cervical Malignancies.
    Mansoori B; Khatri G; Rivera-Colón G; Albuquerque K; Lea J; Pinho DF
    AJR Am J Roentgenol; 2020 Aug; 215(2):292-304. PubMed ID: 32551909
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of
    Sarabhai T; Schaarschmidt BM; Wetter A; Kirchner J; Aktas B; Forsting M; Ruhlmann V; Herrmann K; Umutlu L; Grueneisen J
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):67-76. PubMed ID: 28840302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
    Pinker K; Andrzejewski P; Baltzer P; Polanec SH; Sturdza A; Georg D; Helbich TH; Karanikas G; Grimm C; Polterauer S; Poetter R; Wadsak W; Mitterhauser M; Georg P
    PLoS One; 2016; 11(5):e0155333. PubMed ID: 27167829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of FIGO staging defined by combining MRI and [
    Raffa S; Lanfranchi F; Satragno C; Giannelli F; Marcenaro M; Coco A; Cena SE; Sofia L; Marini C; Mammoliti S; Levaggi A; Tagliafico AS; Sambuceti G; Barra S; Morbelli S; Belgioia L; Bauckneht M
    Curr Probl Cancer; 2023 Dec; 47(6):101007. PubMed ID: 37684197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/MR imaging for the evaluation of cervical cancer during pregnancy.
    Ishiguro T; Nishikawa N; Ishii S; Yoshihara K; Haino K; Yamaguchi M; Adachi S; Watanabe T; Soeda S; Enomoto T
    BMC Pregnancy Childbirth; 2021 Apr; 21(1):288. PubMed ID: 33838651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
    Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA
    Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of parametrial infiltration in cervical cancer with voxel-based segmentation of integrated
    Wang T; Sun H; Han F; Sun W; Chen Z
    Eur J Radiol; 2019 Sep; 118():147-152. PubMed ID: 31439234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
    Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
    Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/MRI in Gynecologic Malignancy.
    Larson M; Lovrec P; Sadowski EA; Pirasteh A
    Radiol Clin North Am; 2023 Jul; 61(4):713-723. PubMed ID: 37169433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
    Lin CY; Lin CL; Kao CH
    Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma.
    Rockall AG; Barwick TD; Wilson W; Singh N; Bharwani N; Sohaib A; Nobbenhuis M; Warbey V; Miquel M; Koh DM; De Paepe KN; Martin-Hirsch P; Ghaem-Maghami S; Fotopoulou C; Stringfellow H; Sundar S; Manchanda R; Sahdev A; Hackshaw A; Cook GJ;
    Clin Cancer Res; 2021 Dec; 27(23):6457-6466. PubMed ID: 34526364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study.
    Vandecasteele K; Delrue L; Lambert B; Makar A; Lambein K; Denys H; Tummers P; Van den Broecke R; Villeirs G; De Meerleer G
    Int J Gynecol Cancer; 2012 May; 22(4):630-7. PubMed ID: 22237382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of distant metastatic disease by positron emission tomography with
    Lin A; Ma S; Dehdashti F; Markovina S; Schwarz J; Siegel B; Powell M; Grigsby P
    Int J Gynecol Cancer; 2019 Mar; 29(3):487-491. PubMed ID: 30739082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
    Lee DH; Kim SH; Joo I; Hur BY; Han JK
    Eur J Radiol; 2016 Jun; 85(6):1085-91. PubMed ID: 27161056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Dag Z; Yilmaz B; Dogan AK; Aksan DU; Ozkurt H; Kızılkaya HO; Arslan D
    Brachytherapy; 2019; 18(2):154-162. PubMed ID: 30594422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.
    Manganaro L; Lakhman Y; Bharwani N; Gui B; Gigli S; Vinci V; Rizzo S; Kido A; Cunha TM; Sala E; Rockall A; Forstner R; Nougaret S
    Eur Radiol; 2021 Oct; 31(10):7802-7816. PubMed ID: 33852049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/MRI for Lung Cancer Staging.
    Ohno Y; Koyama H; Lee HY; Yoshikawa T; Sugimura K
    J Thorac Imaging; 2016 Jul; 31(4):215-27. PubMed ID: 27075745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative pelvic MRI and 2-[
    Fasmer KE; Gulati A; Dybvik JA; Wagner-Larsen KS; Lura N; Salvesen Ø; Forsse D; Trovik J; Pijnenborg JMA; Krakstad C; Haldorsen IS
    Eur Radiol; 2023 Jan; 33(1):221-232. PubMed ID: 35763096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.